SAT0035 Impact of Corticosteroid Use on Remission Sustainability and Infection Rates among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on A Real-World Population

Background According to current treatment guidelines short-term treatment with corticosteroids (CS) can be considered in rheumatoid arthritis (RA) patients treated with a traditional and/or biologic DMARD,and should be tapered as rapidly as clinically feasible1,2. Objectives The aim of the current analysis was to examine the use of systemic CS among patients in remission, to evaluate their usefulness in sustaining disease remission, and assess …